Journal of Clinical Case Reports

Patient with a Pituitary Adenoma Haemorrhage and Total Ophtalmophlegie under Treatment with ASS and Plavix as a Secondary Stroke Prophylaxis

Abstract

Orlin Pavlov*, Mirchev Nikolay, Obersheimer Jens and Behr Robert

In our case report, we discuss a patient, who underwent a dual antiplatelet therapy as a secondary prevention of stroke. To our knowledge, there are no other cases in the literature reviews about pituitary haemorrhage on dual antiplatetelet therapy. The 7^th most common reason for intrapituitary haemorrhage is aspirin. However, the risk for bleeding was not considered when a dual therapy was administered.

The patients, who have suffered a stroke, need a suitable secondary stroke prophylaxis. The dual therapy has shown advantages over the monotherapy with aspirin or with clopidogrel. The personal approach to every patient, who has suffered a stroke, has to be taken. The pituitary adenoma can increase the risk for intracranial bleeding, when a dual therapy is used as a second stroke prophylaxis.